Friday, November 29, 2013
Amgen’s new class of cholesterol drug cuts LDL by 52 percent, study says.
Reuters (11/20, Berkrot, Pierson) reports Amgen Inc.’s experimental heart medicine belonging to a new class of drugs caused a decline in bad LDL cholesterol by 52 percent, without any major jump in serious side effects, after one year. The medicine, evolocumab, belongs to a class of drugs called PCSK9 inhibitors. The side effects were compared with those caused by drugs generally used to treat cholesterol such as statins, reports Reuters. Study results were presented Tuesday at the American Heart Association meeting in Dallas.
Subscribe to:
Post Comments (Atom)
Sometimes the important paraphrasing can make writing better and this is why the perfect using of paraphrasing with the help of this page http://www.realnurseguide.com/6-monumental-nursing-resume-tips/ and you will get the whole.
ReplyDeleteYou need to hire some professional people who can really work on the statement writings. Check this http://www.imgfellowshipapplication.com/img-cover-letter-for-fellowship/ as they are really good at statements writings site.
ReplyDeleteThere have few writers who are working on the dental personal writing side. This site http://www.gsmatched.com/best-residency-personal-statement-service-and-its-team/ could provide you such kind of people.
ReplyDeleteA personal statement is all about you and your quality and strength. If you want to write ophthalmology fellowship personal statement you must need help from an expert and you can get that from here http://www.cspersonalstatements.com/services/ check if you want to get a unique paper.
ReplyDeleteWriting their gastroenterology fellowship personal statement is the big challenge. If your writing isn’t your strongest suit or if you feel that you will need that extra hand then helpful link for tips and suggestion.
ReplyDelete